Publication Name	World Journal of Hepatology
Manuscript ID	94784
Country	China

Received	2024-03-25 11:52
Peer-Review Started	2024-03-25 11:52
To Make the First Decision
Return for Revision	2024-08-16 06:48
Revised	2024-08-22 05:24
Second Decision	2024-08-28 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-08-28 08:48
Articles in Press	2024-08-28 08:48
Publication Fee Transferred	2024-08-28 09:34
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-12 09:36
Publish the Manuscript Online	2024-09-23 10:30

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Case Report
Article Title	Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature
Manuscript Source	Unsolicited Manuscript
All Author List	Yu Gong
ORCID	Author(s) ORCID Number Yu Gong http://orcid.org/0000-0003-2314-4907
Funding Agency and Grant Number
Corresponding Author	Yu Gong, MD, Doctor, Doctor, Department of Intensive Care Unit, Fudan university affiliated Zhongshan Hospital, No. 1609 Xietu Road, Xuhui District, Shanghai 200032, China. gong.yu@zs-hospital.sh.cn
Key Words	Posterior reversible encephalopathy syndrome; Calcineurin inhibitors; Liver transplantation; Prognosis; Case report
Core Tip	Liver transplantation is the only curative option for end-stage liver disease. The rise in liver transplants is accompanied by an increase in the occurrence of neurological complications. The etiology of calcineurin inhibitor (CNI)-related posterior reversible encephalopathy syndrome (PRES) remains unclear, and there are no established preventive measures. Optimal treatment strategies are still a matter of debate. CNIs, although widely used in liver transplants, come with various side effects. Therefore, when new neurological symptoms arise in liver transplant patients on CNIs who meet the diagnostic criteria for PRES, a cerebral magnetic resonance imaging should be promptly conducted to provide diagnostic evidence. Initiating treatment promptly upon confirming the diagnosis is essential for enhancing clinical outcomes.
Publish Date	2024-09-23 10:30
Citation	<p>Gong Y. Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature. <i>World J Hepatol</i> 2024; 16(9): 1297-1307</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i9/1297.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i9.1297

Full Article (PDF)	WJH-16-1297-with-cover.pdf
CARE Checklist–2016	94784-CARE-Checklist-2016.pdf
Manuscript File	94784_Auto_Edited_080138.docx
Answering Reviewers	94784-answering-reviewers.pdf
Audio Core Tip	94784-audio.m4a
Conflict-of-Interest Disclosure Form	94784-conflict-of-interest-statement.pdf
Copyright License Agreement	94784-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	94784-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	94784-non-native-speakers.pdf
Peer-review Report	94784-peer-reviews.pdf
Scientific Misconduct Check	94784-scientific-misconduct-check.png
Scientific Editor Work List	94784-scientific-editor-work-list.pdf
CrossCheck Report	94784-crosscheck-report.png
CrossCheck Report	94784-crosscheck-report.pdf